GSK PLC 2024 AR2
The report outlines GSK's financial and sustainability performance for the fiscal year 2024, highlighting a 7% increase in turnover to £31.4 billion, driven by strong momentum in Specialty Medicines. In R&D, the company achieved a record 13 positive phase III clinical trial readouts and progressed key assets in respiratory, oncology, and HIV. On environmental targets, GSK reduced its operational carbon emissions (Scope 1 and 2) by 12% since 2023 and maintained 100% good water stewardship across its sites. Additionally, the company achieved a second-place ranking in the Access to Medicine Index and continued its commitment to achieving net-zero emissions by 2045.
Company: GSK PLC
Sector: Manufacturing
Country: United Kingdom
Year: 2024
Type: AR2
Pages: 113
GSK PLC
The report outlines GSK's financial and sustainability performance for the fiscal year 2024, highlighting a 7% increase in turnover to £31.4 billion, driven by strong momentum in Specialty Medicines. In R&D, the company achieved a record 13 positive phase III clinical trial readouts and progressed key assets in respiratory, oncology, and HIV. On environmental targets, GSK reduced its operational carbon emissions (Scope 1 and 2) by 12% since 2023 and maintained 100% good water stewardship across its sites. Additionally, the company achieved a second-place ranking in the Access to Medicine Index and continued its commitment to achieving net-zero emissions by 2045.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Net Zero Target
Employees